HME
HME · February 14, 2022
The COVID-19 PHE declaration could expire. This potentially impacts the waivers that have simplified the process for qualifying a patient for home oxygen therapy.
HME · September 11, 2021
According to the article, "Price increases and freight surcharges have HME providers feeling “squeezed” – and in some cases, looking for other sources of equipment, they say."
HME · February 23, 2021
The Coronavirus Disease 2019 (COVID-19) pandemic has caused an increase in the use of pulse oximeters, and a recent report suggests that the devices may be less accurate in people with dark skin pigmentation. The U.S. Food and Drug Administration (FDA) is informing patients and health care providers that although pulse oximetry is useful for estimating blood oxygen levels, pulse oximeters have limitations and a risk of inaccuracy under certain circumstances that should be considered.
HME · February 18, 2021
Read about two cases of fraud schemes, as reported by the United State Department of Justice. One is about braces and other durable medical equipment (DME), and the other is about a multi-million dollar Medicare fraud scheme.
HME · November 19, 2020
Regardless of the COVID-19 pandemic, the need to serve increasing numbers of home respiratory patients continues to expand. How do HME providers meet that demand?
HME · August 14, 2020
"The news that CMS planned to resume audits by Aug. 3 took many by surprise. Then CMS said it would resume audits in a phased approach. What are the details and what can providers expect?"
HME · July 05, 2020
The Independent Medical Retailers (IMR) is looking to shake up how the retail game is played when it comes to durable medical equipment (DME) and home medical equipment (HME). #DME #HMDR #HME
HME · June 30, 2018
OIG says, "Most Medicare claims that DME suppliers submitted for replacement PAP device supplies did not comply with Medicare requirements."
HME · December 05, 2017
"Since Maine does not require a medical device license for the sale of medical supplies, this may be an indication Amazon may not enter the drug supply chain, RBC analysts said." Source: Amazon cancels pharma license application in Maine, raising more questions about its health-care plans - CNBC